Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-055899
Filing Date
2021-09-14
Accepted
2021-09-14 16:17:16
Documents
1
Period of Report
2021-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3959
  Complete submission text file 0001209191-21-055899.txt   5341
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LYELL IMMUNOPHARMA, INC. 400 EAST JAMIE COURT, SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address
Homans Elizabeth (Reporting) CIK: 0001866220 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 211252579